Navigation

Developing NICE medical technologies guidance

This page describes how NICE develops Medical Technology Guidance. Guidance considers a single medical device or diagnostic technology which provides equivalent or enhanced clinical outcomes for equivalent or reduced cost. See all medical technologies assessments currently in development.

1. Notification
Anyone can request NICE consider a medical technology for guidance by completing our notification form. NICE will assess whether a notified technology falls within the remit of the programme and meets the programme eligibility criteria

2. Selection
The NICE technical team produce a briefing note on eligible technologies based on the notification form and information gathered from expert and patient advisers. The Medical Technologies Advisory Committee selects which technologies are suitable for guidance production and routes them to the relevant NICE guidance producing programme.

3. Scope prepared
The scope defines the disease(s), the patients and the technology covered by the assessment and the questions it aims to answer. The draft scope is developed using the manufacturers' notification, opinion from Expert Advisers and patient organisations, and the Committee. The draft scope is made available for comment by registered stakeholders. The scope is then finalised taking into account comments from stakeholders and published on the nice website.

4. Manufacturer's submission
NICE invites manufacturer(s) to respond to the questions raised in the scope in their full submission which must be received by NICE in no more than six weeks (clinical evidence after two weeks, economic evidence within six weeks). Download the template for the manufacturer´s (sponsor´s) submission to complete a response.

5. Assessment report prepared
NICE commissions an independent academic centre to review and critique the evidence on the technology and prepare an Assessment Report.

6. Medical Technologies Advisory Committee meeting
The MTAC is an independent advisory Committee which meets monthly, in public. It considers all the evidence presented and formulates draft recommendations. Read more about the Medical Technologies Advisory Committee.

7. Medical Technologies consultation document (MTCD) produced
The Advisory Committee makes its provisional recommendations in the MTCD. The MTCD is available on our website so that stakeholders, health professionals and members of the public can comment on it. Commentators have four weeks to comment on the MTCD.

8. Final guidance produced
The Committee considers the comments received on the MTCD then makes its final recommendations on the technology. A list of the guidance already published by the programme is also available.

9. Consultees notified
Once NICE's Guidance Executive has approved the final guidance, it is open to resolution, during which time individuals or organisations who commented on the draft guidance may request corrections to the guidance if they consider there has been a breach of process or there are factual errors.

10. Guidance issued
If there are no resolution requests, NICE issues its final guidance to the NHS in England.

Further information

This page was last updated: 02 March 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.